ClinicalTrialsFinder
RecruitingNCT01390675

Anesthesia for Catheter Aortic Valve ImplantATIOn Registry

Sponsor

Deutsches Herzzentrum Muenchen

Enrollment

10,000 participants

Start Date

Jun 1, 2011

Study Type

OBSERVATIONAL

Conditions

Heart FailureAnesthesiaExcessive Amount of Blood / Fluid TransfusionIntraoperative Cardiac Arrest During Cardiac SurgeryCritical IncidentFailed Conscious Sedation During Procedure

Summary

In modern cardiac surgery and cardiology Transcatheter Aortic Valve Implantation (TAVI) is an emerging procedure for high-risk patients that are assumed to be otherwise inoperable. The investigators want to evaluate the specific intraoperative anesthesiologic characteristics cardiac anesthesiologists have to face during these procedures.

Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \- Patients undergoing transcatheter aortic valve implantation (TAVI)

Exclusion Criteria1

  • \- Refusal by patient

Locations(1)

Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München

Munich, Bavaria, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01390675

Related Trials

Mind Your Heart-II

NCT054311921 location

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT06424288652 locations

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

NCT071917301 location

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370641 locations

Timing of Coronary Angiography in NSTEMI Complicated by Acute HF

NCT0700216420 locations